Literature DB >> 5346418

Erythromycin in early syphilis.

W L Fernando.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5346418      PMCID: PMC1048464          DOI: 10.1136/sti.45.3.200

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


× No keyword cloud information.
  9 in total

1.  Treatment of early syphilis with erythromycin.

Authors:  A B GREAVES
Journal:  Public Health Rep       Date:  1961-10       Impact factor: 2.792

2.  [The treatment of early syphilis with erythromycin].

Authors:  W GERTLER
Journal:  Dermatol Wochenschr       Date:  1961-03-04

3.  Erythromycin in the treatment of early syphilis; a preliminary report.

Authors:  C H MONTGOMERY; J M KNOX
Journal:  AMA Arch Derm       Date:  1959-08

4.  Erythromycin in treatment of early syphilis.

Authors:  C H MONTGOMERY; J M KNOX; G W SCIPLE; E M VANDER STOEP
Journal:  Arch Intern Med       Date:  1961-05

5.  Erythromycin in venereal diseases.

Authors:  L J ALEXANDER; A G SCHOCH
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1954-03

6.  Oral erythromycin in the treatment of early syphilis.

Authors:  M B MOORE; E M VANDERSTOEP; J M KNOX; C H MONTGOMERY
Journal:  J Invest Dermatol       Date:  1962-05       Impact factor: 8.551

7.  Co-operative evaluation of treatment for early syphilis. Preliminary report with special reference to spectinomycin sulphate (actinospectacin).

Authors:  J B Lucas; E V Price
Journal:  Br J Vener Dis       Date:  1967-12

8.  [Trials of early syphilis therapy with erythromycin].

Authors:  J Wojtkiewiczowa; B Toruniowa
Journal:  Przegl Dermatol       Date:  1965 Sep-Oct

9.  Susceptibilities of Kazan, Nichols, and Reiter strains of Treponema and pleuropneumonia-like organisms to the antibiotic erythromycin (ilotycin).

Authors:  R KELLER; H E MORTON
Journal:  Am J Syph Gonorrhea Vener Dis       Date:  1953-07
  9 in total
  1 in total

Review 1.  Current status of the treatment of syphilis.

Authors:  E Barrett-Connor
Journal:  West J Med       Date:  1975-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.